$AVMXY Pr. chart is staging OTC $2.21 Called 9/3
Post# of 98059
Posted On: 04/20/2016 10:40:26 AM
$AVMXY Pr. chart is staging
OTC $2.21
Called 9/30/15 $1.09
Website
(TM) Skin Regeneration Technology
Decreases Size and Pain in Chronic Wounds
Marketwired (Tue, Apr 19)
Shares Outstanding: 21.25M
Float: 19.71M
% Held by Insiders: N/A
% Held by Institutions: N/A
Headlines
Avita Medical Limited develops and distributes regenerative and tissue-engineered products for the human body to treat a range of wounds, scars, and skin in the Asia Pacific, Europe, the Middle East, Africa, and the Americas. Its lead product is ReCell Spray-On Skin used in various burns, plastic, reconstructive, and cosmetic procedures. The company also manufactures and sells a range of spacers, including Funhaler incentive asthma spacer for the paediatric market; and Breath-A-Tech spacer for the adolescent and adult markets. Avita Medical Limited is headquartered in Royston, the United Kingdom.
Long term 100 % Buy
OTC $2.21
Called 9/30/15 $1.09
Website
(TM) Skin Regeneration Technology
Decreases Size and Pain in Chronic Wounds
Marketwired (Tue, Apr 19)
Shares Outstanding: 21.25M
Float: 19.71M
% Held by Insiders: N/A
% Held by Institutions: N/A
Headlines
Avita Medical Limited develops and distributes regenerative and tissue-engineered products for the human body to treat a range of wounds, scars, and skin in the Asia Pacific, Europe, the Middle East, Africa, and the Americas. Its lead product is ReCell Spray-On Skin used in various burns, plastic, reconstructive, and cosmetic procedures. The company also manufactures and sells a range of spacers, including Funhaler incentive asthma spacer for the paediatric market; and Breath-A-Tech spacer for the adolescent and adult markets. Avita Medical Limited is headquartered in Royston, the United Kingdom.
Long term 100 % Buy
(0)
(0)Scroll down for more posts ▼